Paul Young

New Zealand medical researcher

Paul Young is …
instance of (P31):
humanQ5

External links are
P10283OpenAlex IDA5038005820
P496ORCID iD0000-0002-3428-3083
P1153Scopus author ID57188707997

P185doctoral studentDiane MackleQ92436866
P69educated atVictoria University of WellingtonQ1150437
University of AucklandQ492467
P108employerUniversity of MelbourneQ319078
Capital and Coast District Health BoardQ27991335
Medical Research Institute of New ZealandQ27991340
Wakefield HospitalQ30281073
P734family nameYoungQ12678727
YoungQ12678727
YoungQ12678727
P735given namePaulQ4925623
PaulQ4925623
P106occupationresearcherQ1650915
P5008on focus list of Wikimedia projectNZThesisProjectQ111645234
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q40859004A Binational Multicenter Pilot Feasibility Randomized Controlled Trial of Early Goal-Directed Mobilization in the ICU.
Q90129398A Pilot, Double-Blind, Randomized, Controlled Trial of High-Dose Intravenous Vitamin C for Vasoplegia After Cardiac Surgery
Q61822338A case series of critically ill patients with anti- N-methyl-D-aspartate receptor encephalitis
Q61822321A cluster randomised, crossover, registry-embedded clinical trial of proton pump inhibitors versus histamine-2 receptor blockers for ulcer prophylaxis therapy in the intensive care unit (PEPTIC study): study protocol
Q40099450A comparison of therapeutic hypothermia and strict therapeutic normothermia after cardiac arrest
Q40154245A multicentre audit of temperature patterns after traumatic brain injury
Q53110000A pilot study investigating the effects of remote ischemic preconditioning in high-risk cardiac surgery using a randomised controlled double-blind protocol
Q61822335A protocol for the 0.9% saline versus Plasma-Lyte 148 for intensive care fluid therapy (SPLIT) study
Q91106466A randomized controlled feasibility trial of paracetamol during febrile neutropenia in hemato-oncology patients
Q55552196A systematic review and meta-analysis of the cardioprotective effects of remote ischaemic preconditioning in open cardiac surgery.
Q34508479A systematic review of measurements of physical function in critically ill adults.
Q61822327A two centre observational study of simultaneous pulse oximetry and arterial oxygen saturation recordings in intensive care unit patients
Q40136352Acetaminophen for Fever in Critically Ill Patients with Suspected Infection
Q57786064Acetaminophen for Fever in Critically Ill Patients with Suspected Infection
Q40093711Acetaminophen to treat fever in intensive care unit patients with likely infection: a response from the author of the HEAT trial
Q61359587Acute Kidney Injury With Buffered Crystalloids vs Saline Among ICU Patients—Reply
Q61822330Admitting elderly patients to ICU: is it just about survival?
Q89579726Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock
Q40192124Angiotensin II for the Treatment of Vasodilatory Shock
Q46110167Arterial carbon dioxide tension and outcome in patients admitted to the intensive care unit after cardiac arrest
Q57786128Arterial oxygen tension and mortality in mechanically ventilated patients
Q40177550Association between early peak temperature and mortality in neutropenic sepsis
Q90077193Balanced Crystalloids or 0.9% Saline in Sepsis. Beyond Reasonable Doubt?
Q46834082Can social media bridge the gap between research and practice?
Q61822340Cardiac arrest complicating neostigmine use for bowel opening in a critically ill patient
Q61822325Changes in Temperature Management of Cardiac Arrest Patients Following Publication of the Target Temperature Management Trial*
Q90065889Characteristics and Outcomes of Critically Ill Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Australia and New Zealand
Q89933405Characteristics and Outcomes of Critically Ill Trauma Patients in Australia and New Zealand (2005-2017)
Q64120747Characteristics and Outcomes of Patients with Acute Liver Failure Admitted to Australian and New Zealand Intensive Care Units
Q50137514Characteristics, incidence, and outcome of patients admitted to the intensive care unit with myasthenia gravis
Q38830249Choice of Fluid Therapy and Bleeding Risk After Cardiac Surgery
Q90714671Conservative Oxygen Therapy during Mechanical Ventilation in the ICU
Q91363166Conservative oxygen therapy for mechanically ventilated adults with sepsis: a post hoc analysis of data from the intensive care unit randomized trial comparing two approaches to oxygen therapy (ICU-ROX)
Q47829174Conservative oxygen therapy in mechanically ventilated patients.
Q50939590Conservative versus Liberal Oxygenation Targets for Mechanically Ventilated Patients. A Pilot Multicenter Randomized Controlled Trial.
Q54878265Conservative versus liberal oxygenation targets for mechanically ventilated patients: pilot multicentre randomised trial.
Q89794637Could stress ulcer prophylaxis increase mortality in high-acuity patients?
Q61822336Critical care statistical analysis plans. In reply
Q26765796Crystalloid fluid therapy
Q61822337Crystalloid fluid therapy: is the balance tipping towards balanced solutions?
Q48132933Delivery of titrated oxygen via a self-inflating resuscitation bag.
Q64109337Development and Validation of a Score to Identify Cardiac Surgery Patients at High Risk of Prolonged Mechanical Ventilation
Q91418114Early dysglycemia and mortality in traumatic brain injury and subarachnoid hemorrhage
Q35125357Early mobilization and recovery in mechanically ventilated patients in the ICU: a bi-national, multi-centre, prospective cohort study
Q40297907Early peak temperature and mortality in critically ill patients with or without infection
Q35554858Early temperature and mortality in critically ill patients with acute neurological diseases: trauma and stroke differ from infection
Q50511747Effect of 0.9% Saline or Plasma-Lyte 148 as Crystalloid Fluid Therapy in the Intensive Care Unit on Blood Product Use and Postoperative Bleeding After Cardiac Surgery.
Q38394832Effect of Dexmedetomidine Added to Standard Care on Ventilator-Free Time in Patients With Agitated Delirium: A Randomized Clinical Trial
Q92724594Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine-2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical Ventilation: The PEPTIC Randomized Clinical Trial
Q92724610Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial
Q38402361Effect of a Buffered Crystalloid Solution vs Saline on Acute Kidney Injury Among Patients in the Intensive Care Unit: The SPLIT Randomized Clinical Trial
Q51459178Effect of saline 0.9% or Plasma-Lyte 148 therapy on feeding intolerance in patients receiving nasogastric enteral nutrition.
Q39352547Effect sizes in ongoing randomized controlled critical care trials
Q34995227Expert consensus and recommendations on safety criteria for active mobilization of mechanically ventilated critically ill adults
Q45363431Feasibility and inter-rater reliability of the ICU Mobility Scale
Q40309039Fever and antipyresis in infection
Q48148343Fever control
Q61822318Fever control in critically ill adults. An individual patient data meta-analysis of randomised controlled trials
Q33751352Fever in sepsis: is it cool to be hot?
Q38230165Fever management in intensive care patients with infections
Q40604533Fluid administration, vasopressor use and patient outcomes in a group of high-risk cardiac surgical patients receiving postoperative goal-directed haemodynamic therapy: a pilot study.
Q61822329Fluid management in acute kidney injury
Q53096304HyperOxic Therapy OR NormOxic Therapy after out-of-hospital cardiac arrest (HOT OR NOT): a randomised controlled feasibility trial.
Q43632353Improved survival in critically ill patients: are large RCTs more useful than personalized medicine? Yes.
Q41986972Intensive care triage in Australia and New Zealand.
Q61822328Intensive care unit randomised trial comparing two approaches to oxygen therapy (ICU-ROX): results of the pilot phase
Q92378630Is sepsis treatment heating up?
Q48222626Learning Healthcare Systems Will Protect Patients from Unscientific Practice Variation
Q58574539Mean arterial pressure and mortality in patients with distributive shock: a retrospective analysis of the MIMIC-III database
Q54221211Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis.
Q91509961O2, do we know what to do?
Q92436878Outcomes Six Months after Delivering 100% or 70% of Enteral Calorie Requirements during Critical Illness (TARGET). A Randomized Controlled Trial
Q41375730Overview of the study protocols and statistical analysis plan for the Saline versus Plasma-Lyte 148 for Intravenous Fluid Therapy (SPLIT) research program
Q61822320Oxygen therapy in acute resuscitation
Q61822319Oxygen: a new look at an old therapy
Q92263555Practice patterns and perceptions of Australian and New Zealand anaesthetists towards perioperative oxygen therapy
Q61822331Protocol and statistical analysis plan for the Randomised Evaluation of Active Control of Temperature versus Ordinary Temperature Management (REACTOR) trial
Q49844183Protocol summary and statistical analysis plan for the intensive care unit randomised trial comparing two approaches to oxygen therapy (ICU-ROX).
Q90429207Randomised evaluation of active control of temperature versus ordinary temperature management (REACTOR) trial
Q48254902Registrar sleep patterns and supervision during two different rosters in a tertiary Australasian intensive care unit.
Q36800749Remote ischaemic preconditioning does not alter perioperative cytokine production in high-risk cardiac surgery
Q51442569Renal nerve and alpha 2-adrenergic action during acute volume expansion in the anaesthetized rat.
Q36096928Renoprotection by remote ischemic conditioning during elective coronary revascularization: A systematic review and meta-analysis of randomized controlled trials
Q61359334Reply to Letter: Could one degree in temperature change the world? Maybe for targeted temperature management!
Q96224343Reply to: Too Many Calories for All?
Q47231447Restrictive or Liberal Red-Cell Transfusion for Cardiac Surgery
Q53729095Saline Is the Solution for Crystalloid Resuscitation.
Q59760344Six-Month Outcomes after Restrictive or Liberal Transfusion for Cardiac Surgery
Q39304711Statistical analysis plan for the HEAT trial: a multicentre randomised placebo-controlled trial of intravenous paracetamol in intensive care unit patients with fever and infection
Q37961667Systematic review and meta-analysis of the effects of antipyretic medications on mortality in Streptococcus pneumoniae infections
Q93036296Targeted hypothermia versus targeted Normothermia after out-of-hospital cardiac arrest (TTM2): A randomized clinical trial-Rationale and design
Q61362071The "sweet spot" for physiological targets in critically ill patients
Q38768363The Fragility Index in Multicenter Randomized Controlled Critical Care Trials
Q40264807The HEAT trial: a protocol for a multicentre randomised placebo-controlled trial of IV paracetamol in ICU patients with fever and infection
Q40833270The ICU Mobility Scale Has Construct and Predictive Validity and Is Responsive. A Multicenter Observational Study
Q47552441The Plasma-Lyte 148 v Saline (PLUS) study protocol: a multicentre, randomised controlled trial of the effect of intensive care fluid therapy on mortality
Q91509997The Plasma-Lyte 148 versus Saline (PLUS) study protocol amendment
Q91727536The Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia (REMAP-CAP) Study: Rationale and Design
Q90128511The Risk of Hyperoxemia in ICU Patients. Much Ado About O2
Q43957768The association between SpO2 values and mortality--interpret with caution
Q53110007The association between early arterial oxygenation and mortality in ventilated patients with acute ischaemic stroke.
Q61359290The authors reply
Q37973951The effect of hyperoxia following cardiac arrest - A systematic review and meta-analysis of animal trials.
Q38203397The impact of oxygen and carbon dioxide management on outcome after cardiac arrest
Q89897580The implications of the PEPTIC trial for clinical practice
Q47386303Timing of Initiation of Renal Replacement Therapy in Critically Ill Patients With Acute Kidney Injury
Q97552617Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury
Q91050433Trauma-related admissions to intensive care units in Australia: the influence of Indigenous status on outcomes
Q50428628Validation of a classification system for causes of death in critical care: an assessment of inter-rater reliability
Q92005956Vasopressin in septic shock: what we know and where to next?
Q91271520Vitamin C therapy for patients with sepsis or septic shock: a protocol for a systematic review and a network meta-analysis
Q92378659Vitamin C, Hydrocortisone and Thiamine in Patients with Septic Shock (VITAMINS) trial: study protocol and statistical analysis plan
Q93345285What should we target after TARGET?
Q40617636What's new on balanced crystalloid solutions?
Q92890813When less is more in the active management of elevated body temperature of ICU patients
Q58594011Why don't multicenter randomized controlled trials (RCT) confirm the positive findings of single center RCTs in acute care? (Zeno's Paradox of the Tortoise and Achilles revisited)

Q92436866Diane Mackledoctoral advisorP184
Q112574849Oxygen management in New Zealand and Australian intensive care units: A knowledge translation studythesis committee memberP9161